Template talk:Serotonin receptor modulators

Pharmacology Template‑class

This template is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles Template This template does not require a rating on Wikipedia's content assessment scale.

Chemicals Template‑class

This template is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this template or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles Template This template does not require a rating on Wikipedia's content assessment scale.

	Medicine Template‑class
This template is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles Template This template does not require a rating on Wikipedia's content assessment scale.

Molecular Biology: MCB Template‑class

This template is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles Template This template does not require a rating on Wikipedia's content assessment scale. This template is supported by the Molecular and Cell Biology task force.

Should Anabolic-androgenic steroids be moved under Cofactors?.--David Hedlund (talk) 05:34, 2 December 2013 (UTC)[reply]

The navbox Template:Serotonergics can be linked to an article as 1 wikilink, rather than over 875, by displaying it in a navpages-box, as shown below. Some users might have difficulty editing an article, when waiting for the Serotonergics navbox to be reformatted, during each edit-preview.

The following markup connects Serotonergics as a navpage, and defers the 875+ wikilinks, which otherwise cause database links to be updated for those 875+ other articles:

{| class=wikitable width="99%" | bgcolor="#F1F1FC" | {{portal|Medicine}} : '''Related navpages''': :* [[Template:Serotonergics|Serotonergics]] (over 870 topics) |} 

Users editing from smaller devices might have difficulty editing an article, when awaiting the Serotonergics navbox to be reformatted, during each edit-preview, while waiting for the edit-text window to appear, following the extensive typesetting of the 875 wikilinks in the Serotonergics table-box. By using the above navpages-box, then editing an article becomes much, much faster, as the edit-text window quickly appears on the edit page. -Wikid77 (talk) 17:24, 13 April 2010 (UTC)[reply]

The names of a lot of these molecules are not very revealing when it comes to their structural relationship to their effect. I'd really like to make a version of thi template that would have image links which are pictures of the molecule which will show the name on mouse hover and link to that article. I'll have to look into this more but I';m sure theres a simple way to do this RotogenRay (talk) 01:37, 5 July 2014 (UTC)Rotogenray on july 4[reply]

This edit request to Template:Serotonergics has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.

Need to change medifoxamine to a 5-HT2A and 5-HT2C receptor antagonist instead of agonist. 2605:E000:8789:D800:D4BD:CD0A:A5A7:D7C (talk) 19:40, 13 January 2016 (UTC)[reply]

Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format. With the complexity of this topic and the template, I'm not sure what exactly I should be changing here --allthefoxes ^(Talk) 16:44, 20 January 2016 (UTC)[reply]

It looks like this change was done yesterday. Seppi333 (Insert 2¢) 16:47, 20 January 2016 (UTC)[reply]

Should we keep psilocybin in there since it's a prodrug? I think we should remove it since psilocin, it's active sibling, is already there. Cganuelas (talk) 06:11, 30 November 2020 (UTC)[reply]

This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.

Please fix the MMDA (drug) link at the end of the 5-HT2B agonists list. That MMDA entry (there's another one as well but that link is correct) has only one [ character in front, it should have two. 2607:FEA8:E31F:FBC1:E0F4:E500:59C2:F9A5 (talk) 23:47, 12 February 2021 (UTC)[reply]

 Done - see Special:Diff/1006463329. Thank you! DanCherek (talk) 01:05, 13 February 2021 (UTC)[reply]

This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.

ad Chlorprothixene to 5-HT2A antagonist, it has very significant binding affinity in contrary to other typical neuroleptic Yellow whisper (talk) 18:49, 12 November 2021 (UTC)[reply]

 Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format and provide a reliable source if appropriate. ScottishFinnishRadish (talk) 18:54, 12 November 2021 (UTC)[reply]

Done --ἀνυπόδητος (talk) 08:40, 13 November 2021 (UTC)[reply]